Uncategorised - European Medical Journal

Albumin Therapy for Advanced Liver Disease

The role of human albumin therapy in the management of advanced liver disease is not yet fully established across all settings and remains…

Immune and Cholestatic Liver Disease

THIS YEAR, at the European Association for the Study of the Liver (EASL) Congress, there were exciting new developments…

Beyond Diagnosis, Towards Treatment

Non-invasive tests (NIT) were one of the strongest organising themes at the European Association for the Study of the Liver…

Optimising PBC Management

Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease that can progress from persistent inflammation to…

Precision Oncology Across the Spectrum of Liver Tumours

Primary liver cancers pose substantial clinical challenges despite significant advances in surveillance, diagnosis, and systemic therapy…

Advancing Primary Biliary Cholangitis Management

Primary biliary cholangitis (PBC) management in Europe has undergone a significant transition following the European Medicines Agency’s…

Metabolic Dysfunction-Associated Steatotic Liver Disease in Challenging Care Settings

Recently, the global response to hepatitis C virus infection has shown that major liver disease challenges can be reshaped through…

Concomitant Medications Associated with Acute Liver Injury Risk Following AMX/CLAV Exposure

Drug-induced liver injury (DILI) remains a major adverse drug reaction and a leading cause of drug development failure and post-marketing…

Practical Tips for the Interprofessional Management of MASLD

MASLD IS now recognised as the most common chronic liver disease worldwide and a major contributor to liver-related morbidity and mortality…

mRNA COVID-19 Vaccination in Liver Cancer

Immune checkpoint inhibitors (ICI) targeting programmed cell death-1 (PD-1) and programmed death ligand-1 (PD-L1) have transformed the…